ScienceDex / Researcher record
Donovan, Gerald P
- Progenics Pharmaceuticals, Inc. (no department on record)
From the FY2010 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 10% Funded
- Early Career
NIH Funding · FY2010
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2006 | $1,207,698 | 2 | #4,069 |
| 2007 | $1,193,621 | 2 | #5,259 |
| 2010 | $4,143,652 | 1 | #1,174 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20062 records
- FY20072 records
- FY2010 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2010Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2010 award records by amount
NIH award records listing Donovan, Gerald P as a PI. Multi-PI records show the full award amount for context.
- 1RC4AI092728-01RC4Contact PINovel, Non-antibiotic Therapy for Clostridium difficile-Associated Disease$4.1Maward amount
Award organization
Organizations that administered FY2010 awards listing Donovan, Gerald P as a PI.
FY2010 award administered by Progenics Pharmaceuticals, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardProgenics Pharmaceuticals, Inc.
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #4069
- 2006Entered Top 25% NationallyRanked #4069
- 2007$2M Cumulative Funding
- 2010$5M Cumulative Funding
- 2010Entered Top 10% NationallyRanked #1174